Table 3.
Univariate | Multivariate | |||
---|---|---|---|---|
P Value | β (95% CI) | P Value | β (95% CI) | |
PFR | ||||
Age | 0.457 | 0.9 (−1.5 to 3.2) | 0.885 | −0.2 (−2.4 to 2.1) |
Sex | 0.623 | −16.6 (−84.3 to 51.1) | 0.956 | 1.8 (−61.8 to 65.3) |
Septal wall thickness | 0.017 | −9.4 (−17.1 to −1.8) | ||
LOX expression | 0.003 | −185.2 (−301.3 to −69.2) | 0.005 | −188.7 (−315.6 to −61.7) |
Insoluble collagen fraction | 0.003 | −4.6 (−7.4 to −1.7) | ||
PER‐E | ||||
Age | 0.246 | −0.8 (−2.1 to 0.5) | 0.406 | −0.5 (−1.7 to 0.7) |
Sex | 0.547 | −11.5 (−49.7 to 26.7) | 0.975 | 0.6 (−36.1 to 37.2) |
LA diameter | 0.081 | −1.9 (−4.0 to 0.2) | ||
LOX expression | 0.023 | −80.7 (−149.9 to −11.6) | ||
Insoluble collagen fraction | 0.002 | −2.6 (−4.3 to −1.0) | 0.005 | −2.6 (−4.3 to −0.8) |
LATEF | 0.02 | 1.8 (0.3 to 3.3) |
HOCM indicates hypertrophic obstructive cardiomyopathy; LA, left atrial; LATEF, total left atrial ejection fraction; LOX, lysyl oxidase; PER‐E early peak emptying rate; and PFR, peak filling rate.